2022
Cognitive reserve-building activities in MS (CRAMS study)
2021
Rituximab and ocrelizumab treatment of active MS (DanNORMS study)
2021
The effect of a gluten free diet on the permeability of the blood brain barrier in patients with CIS
2021
Autologous hematopoietic stem cell transplantation versus alemtuzumab in MS (RAM-MS)
2021
The effect of medical cannabis on neuropathic pain and spasticity in patients with MS
The year refers to the date of publication (PubMed)
2020
Dimethyl fumarate treatment of primary progressive MS (FUMAPMS study)
2017
Erythropoietin treatment of progressive MS
2016
Minocycline added to subcutaneous interferon β-1a in treatment of relapsing MS (RECYCLINE study)
2015
Trichuris suis ova treatment of relapsing MS
2011
Simvastatin as an add-on therapy to interferon-beta1a for relapsing MS (SIMBOMBIN study)
2011
Simvastatin tretament of patients with opticus neuritis
2010
Combination therapy of methylprednisolone with interferon-beta for relapsing MS (MECOMBIN study)
2009
Combination therapy of methylprednisolone with interferon-beta for relapsing MS (NORMIMS study)
2009
Methylprednisolone and azathioprine for neutralizing antibodies to interferon-beta in patients with MS
1996
Plasma exchange combined with azathioprine in secondary progressive MS
1993
Prednisolone treatment of acute opticus neuritis